Showing results (151-160 of 182) with videos related to
Sort By:
Pageof 19
Leukemia & Lymphoma|June 7, 2017
Brentuximab vedotin consolidation post-autologous stem cell transplant in Hodgkin lymphoma patients at risk of residual disease: number needed to treatAshish Gautam, Yanyan Zhu, Esprit Ma, et al.Journal of Mid-Life Health|May 13, 2026
Tirzepatide-induced Weight Loss in Overweight or Obese Midlife Adults with and without Type 2 Diabetes: A Real-world Comparative Cohort StudyPrabhat Kumar Agrawal, Shambo Samrat Samajdar, Ruchika Garg, et al.Clinical Lung Cancer|April 11, 2022
A Randomized, Open-Label Phase II Study Evaluating Emibetuzumab Plus Erlotinib and Emibetuzumab Monotherapy in MET Immunohistochemistry Positive NSCLC Patients with Acquired Resistance to ErlotinibD Ross Camidge, Teresa Moran, Ingel Demedts, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 2, 2014
Evaluation of antitumor activity using change in tumor size of the survivin antisense oligonucleotide LY2181308 in combination with docetaxel for second-line treatment of patients with non-small-cell lung cancer: a randomized open-label phase II studyRonald Natale, Fiona Blackhall, Dariusz Kowalski, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2013
Randomized international phase III trial of ERCC1 and RRM1 expression-based chemotherapy versus gemcitabine/carboplatin in advanced non-small-cell lung cancerGerold Bepler, Charles Williams, Michael J Schell, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2014
A phase I, pharmacokinetic, and pharmacodynamic study of panobinostat, an HDAC inhibitor, combined with erlotinib in patients with advanced aerodigestive tract tumorsJhanelle E Gray, Eric Haura, Alberto Chiappori, et al.Cornea|June 9, 2012
Activated macrophages induce neovascularization through upregulation of MMP-9 and VEGF in rat corneasZhan-rong Li, Yong-ping Li, Miao-li Lin, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2006
Increased bioavailability of intravenous versus oral CI-1033, a pan erbB tyrosine kinase inhibitor: results of a phase I pharmacokinetic studyGeorge R Simon, Christopher R Garrett, Stephen C Olson, et al.Cancer|October 20, 2011
Molecular classification of nonsmall cell lung cancer using a 4-protein quantitative assayValsamo K Anagnostou, Anastasios T Dimou, Taxiarchis Botsis, et al.Molecular & Cellular Proteomics : MCP|July 31, 2008
Proteomic contributions to personalized cancer careJohn M Koomen, Eric B Haura, Gerold Bepler, et al.Pageof 19